Hyodeoxycholic acid: a new approach to gallstone prevention

Area of Science:

• Biochemistry
• Gastroenterology
• Metabolic Research

Background:

• Cholesterol gallstones are a common health issue.
• Bile acid composition influences cholesterol crystallization and gallstone formation.
• Hepatic hydroxymethylglutaryl coenzyme A reductase regulates cholesterol synthesis.

Purpose of the Study:

• To investigate the gallstone-preventive effects of hyodeoxycholic acid (HDCA) and 6 beta-hyodeoxycholic acid (6bHDCA).
• To determine the impact of these bile acids on cholesterol metabolism and bile composition.
• To elucidate the mechanism by which these bile acids inhibit cholesterol gallstone formation.

Main Methods:

• Prairie dogs were fed a lithogenic diet supplemented with HDCA or 6bHDCA.
• Bile saturation, cholesterol levels (serum and liver), and hepatic hydroxymethylglutaryl coenzyme A reductase activity were measured.
• Gallbladder bile was analyzed for the presence of liquid crystals.

Main Results:

• HDCA and 6bHDCA administration prevented cholesterol gallstone and crystal formation.
• Bile remained supersaturated with cholesterol, yet gallstones did not form.
• These bile acids inhibited hepatic hydroxymethylglutaryl coenzyme A reductase activity, preventing cholesterol accumulation.
• Gallbladder bile contained abundant liquid crystals, indicating cholesterol remained in a non-crystalline phase.

Conclusions:

• Hyodeoxycholic acid and 6 beta-hyodeoxycholic acid are effective in preventing cholesterol gallstone formation.
• These bile acids appear to inhibit gallstone formation by stabilizing cholesterol in a liquid crystalline state.
• Targeting bile acid metabolism may offer a therapeutic strategy for cholesterol gallstone disease.